Hibiwash 40 mg/ml, Lösung zur Anwendung auf der Haut

7680701820027 CH-70182 Lösung zur Anwendung auf der Haut

Associated product:

HIBIWASH 40 mg/ml sol 250 ml

No image available

Article details

Package size
250
Selling units
250
Measure
ml
Galenic form
Lösung zur Anwendung auf der Haut
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/03/2026
Patient information leaflet
Français
18/03/2026
Patient information leaflet
Italien
18/03/2026
Summary of Product Characteristics
Allemand
18/03/2026
Summary of Product Characteristics
Français
18/03/2026
Summary of Product Characteristics
Italien
18/03/2026

Detailed composition

Substance Quantity Type Category
chlorhexidini digluconas
40.0 MG Substance Wirkstoff (Principe actif)
poloxamerum 237
- Substance HNIDK
alcohol isopropylicus
- Substance HNIDK
cocamidopropylamini oxidum
- Substance HNIDK
glycerolum
- Substance HNIDK
macrogol 7 glyceroli cocoates
- Substance HNIDK
d-glucono-1,5-lactonum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua purificata
- Substance HNIDK

Authorization holder

MÖLNLYCKE HEALTH CARE AG

8952 Schlieren

Authorization information

Swissmedic authorization number
70182
Drug name
Hibiwash, Lösung zur Anwendung auf der Haut
Galenic form
LSKU
ATC Code
D08AC02
Authorization status
Z
Dispensing category
D
First authorization
17/12/2025
Authorization expiration date
16/12/2030
IT Number
10.09.1.
Domain
Human medicine
Field of application
Prä- und postoperative Desinfektion der Haut und Hände

Package details

Description (FR)
HIBIWASH 40 mg/ml sol 250 ml
Description (DE)
HIBIWASH 40 mg/ml Lös 250 ml
Market launch
01/08/2026
Narcotic (BTM)
No

Other package sizes (3)

HIBIWASH 40 mg/ml sol 125 ml
125 ML
GTIN: 7680701820010
View
HIBIWASH 40 mg/ml sol 500 ml
500 ML
GTIN: 7680701820034
View
None
5 L
GTIN: None
Not in V1
Buy us a coffee Explore the data